VF
RVLP

Virtu Financial’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Virtu Financial’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-39,818
Closed -$45K – 2344
2022
Q4 		$45K Buy
39,818
+16,983
+74% +$27.1K 0.01% 1103
2022
Q3 		$48K Buy
+22,835
New +$44.4K ﹤0.01% 1215

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Virtu Financial's RVLP Position: Q1 2023 in Review

Virtu Financial sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2023, closing a stake of 39,818 shares — an estimated $45K sold.

Virtu Financial first reported a position in RVLP in Q3 2022 and held it in 2 quarters. The position peaked at $48K in Q3 2022. 41 funds tracked by Wall St. Rank hold RVLP as of Q1 2023.

  • Virtu Financial reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 39,818 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2023, an estimated $45K.
  • Virtu Financial first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2022 and held it in 2 quarters.
  • Virtu Financial's RVL Pharmaceuticals plc Ordinary Shares position peaked at $48K in Q3 2022.
  • 41 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.